BioSpace News Archive

Genetown

Oxurion to Participate in Upcoming June 2023 Conferences

Oxurion NV, a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced that the company will participate in three conferences in June:

June 1, 2023
·
1 min read
Drug Development

Pneumagen raises £8m to accelerate Phase 2 clinical development of Neumifil for the prevention & treatment of viral respiratory tract infections

Pneumagen announced that it has secured £8 million in financing from existing and new investors to support the continued Phase 2 development of Neumifil in Chronic Obstructive Pulmonary Disease patients suffering from virus induced exacerbations.

June 1, 2023
·
3 min read
Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe

Croma-Pharma announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets including Germany, the United Kingdom, and Ireland.

June 1, 2023
·
3 min read
BioMidwest

Exact Sciences to participate in June 2023 investor conferences

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, announced that company management will participate in the following conferences and invited investors to participate by webcast.

June 1, 2023
·
1 min read
BioMidwest

Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting

Biodesix, Inc. announced that three new scientific abstracts will be presented as part of the 2023 American Society of Clinical Oncology Annual Meeting including a poster presented by Friends of Cancer Research featuring genomic data contributed by Biodesix and other organizations.

June 1, 2023
·
5 min read
Biotech Beach

REALM IDx Launches REALM Pharma Services to Improve Drug Development and Research

REALM IDx announced the launch of REALM Pharma Services, an end-to-end discovery, translational research, and clinical trial service for biotechnology and pharmaceutical partners.

June 1, 2023
·
3 min read
Business

NMD Pharma appoints Daniel Brennan as SVP, Corporate and Commercial Strategy

NMD Pharma A/S announces the appointment of Daniel Brennan as Senior Vice President, Corporate and Commercial Strategy with immediate effect.

June 1, 2023
·
3 min read
Genetown

Voyager Therapeutics to Present at the Jefferies Healthcare Conference

Voyager Therapeutics, Inc., a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, announced that CEO Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023, at 3:30 p.m. ET.

June 1, 2023
·
1 min read
Lone Star Bio

Orthofix Announces First Presentation of Seven-Year Outcome Data for the M6-C Artificial Cervical Disc With Other Clinical and Scientific Abstracts at the ISASS Annual Meeting

Orthofix Medical Inc today announced the presentation of multiple clinical and scientific abstracts during the International Society for the Advancement of Spine Surgery (ISASS) annual meeting in San Francisco June 1-3, 2023.

June 1, 2023
·
7 min read
ADC Therapeutics to Participate in the Jefferies Healthcare Conference

ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 8th at 8:30 a.m. EDT.

June 1, 2023
·
4 min read